Neutral
Apellis earnings up next: Last report before Biogen takeover?
Apellis Pharmaceuticals is set to report its first-quarter earnings, which could be its last as an independent company before Biogen completes its $5....
APLS
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest APLS News
Neutral
Research APLS on:
Ad Space